Delivery Order SPE2DB20D3103-SPE2DB24FP1E2

Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,260.46 firm fixed-price delivery order is for the supply of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" with a completion date of July 3, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $1,053.76. The contract is for the supply of the pharmaceutical product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. This award is not designated as a Set-Aside contract. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of pharmaceutical products, specifically ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, to the Defense Logistics Agency (DLA). The $1,283.84 firm fixed price delivery order has an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distributor in the U.S., has been awarded this contract as well as indefinite delivery contracts (IDCs) by the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of a specific pharmaceutical product - ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $6,793.28, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a potential value of up to $999,999,999.00 through December 31, 2025. The purpose of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,337.99 for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML". The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, ZEPBOUND 15 MG/0.5 ML PEN 0.5ML, to the Defense Logistics Agency (DLA). The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,698.10 for the supply of the pharmaceutical product "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML". The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which is the primary logistics provider for the U.S. Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,050.42 firm fixed-price delivery order is for the supply of the prescription drug "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML". This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, specifically ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,580.64 and is a Delivery Order under a Firm Fixed Price contract type. The contracting agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP1E2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, including the medication ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, to the Defense Logistics Agency (DLA). The $1,053.76 firm fixed price Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain to efficiently fulfill government contracts for essential medical commodities.

Generated 9/9/24, 11:00 AM